Sessions

CAR-T & Beyond: Future Cell Based Immunotherapeutic Strategies
Starting with the End in Mind: Translating Academic Research into Commercial Products
Innovative Technologies as a Driver of European CGT Commercialisation & Successful Market Adoption
Cross Country Collaboration for Development, Commercialisation and Access
The EU Health Technology Assessment Regulations: Pricing & Reimbursement Opportunities of Novel Therapeutics in Europe
A CGT Retrospective: Best Practice & Evidence Generation for Pricing, Reimbursement & Regulatory Approval
Disruptive Developments Digitalisation, AI and Virtualisation Supporting ATMP Progress

CAR-T & Beyond: Future Cell Based Immunotherapeutic Strategies

07 Sep 2023
15:00